Navigation Links
Cryo-Cell International, Inc. Reports First Quarter 2008 Results
Date:4/10/2008

p>As of February 29, 2008, the Company had approximately $4.2 million in available cash, cash equivalents, marketable securities and other investments. The Company had no long-term debt at the end of the quarter.

On November 1, 2007 Cryo-Cell commercially launched the C'elle menstrual stem cell preservation and storage service, an innovative and proprietary new service based on the Company's extensive patent portfolio of intellectual property. C'elle represents a major milestone in the Company's strategic plan to achieve product diversification, and the new service is expected to contribute to future revenue growth and earnings. In parallel, Cryo-Cell is also implementing plans to license C'elle technology in strategic global markets that may potentially serve to generate additional new sources of revenue.

"We are encouraged by Cryo-Cell's improved performance in the first quarter of 2008. In accordance with our long-term strategic plan, we believe that the Company is progressing well in the early phase of fiscal 2008," stated Mercedes Walton, Chairman and Chief Executive Officer. "In 2006, following nine consecutive quarters of profitability spanning the first quarter of 2004 through the second quarter of 2006, Cryo-Cell's Board of Directors made the deliberate decision to forsake continued near-term profitability in order to invest in the long-term growth of our business. At this juncture, we are pleased with early indicators that we believe reflect growing interest in C'elle, as both a standalone direct-to-consumer service and as a uniquely differentiated combination service offered along with our signature UCord(R) product."

"Notwithstanding formidable challenges associated with new product development, intensified industry competition and the overall impact of the economy on discretionary consumer spending, the Company has maintained a steadfast focus on our comprehensive strategic plan to achieve product diversification and advance commerc
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
2. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
5. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
6. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
7. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
8. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
9. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
10. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
11. Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Verenium Corporation (Nasdaq: ... focused on the development and commercialization of high-performance enzymes, ... Chief Financial Officer, will present at two upcoming conferences. ... Black will present at the Second Annual Marcum LLP ... Grand Hyatt Hotel in New York City.  The presentation ...
(Date:5/23/2013)... 2013 Pusan National University Yangsan Hospital, ... and contract research company focused on research and ... today a publication reporting the induction of functional ... and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.). ... the May 15 th , 2013 issue of ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... of genetics-based ancestry tracing for people of African ... myDNAmix Admixture product offering. For people of all ... genetic make-up from five distinct populations: Indigenous Americas ... Europe and India Subcontinent. , Originally ...
(Date:5/23/2013)... PA (PRWEB) May 23, 2013 Bed ... that the university had already confirmed it. Meanwhile, My Cleaning ... help bed bug victims fight the pests without using harmful ... posted on May 15, 2013, the affected building was actually ... it being infested was said made on May 13 and ...
Breaking Biology Technology:Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2
... somehow survived where other traditional marketing tools and old ... must face harsher realities once again, all to ensure ... Web sites are simply doomed. While billions of Web ... clash into the billions of surfing customers and simply ...
... Ted Kanavas, R-Brookfield, called on the Legislature and the ... Development Fund. , ,The fund would use existing information ... Administration and segregate a portion of the funds for ... would not flow into this fund. , ,This fund ...
... Corporation and First Data Corporation jointly ... provides for the purchase of substantially all of the ... approximately $610 million in cash. As the majority shareholder ... million and NYCE will become a Metavante subsidiary. , ...
Cached Biology Technology:The mysteries and the future of Web sites 2The mysteries and the future of Web sites 3The mysteries and the future of Web sites 4Metavante and First Data to buy PIN-debit company NYCE 2
(Date:5/23/2013)... medics have succeeded in treating cerebral palsy with autologous ... damage, a 2.5 year old boy had been in ... survival. Just two months after treatment with the cord ... the following months, the child learned to speak simple ... from a Korean study, dispel the long-held doubts about ...
(Date:5/23/2013)... Frontiers, one of the world,s largest and fastest ... new journal, Frontiers in Bioengineering and Biotechnology ... all specialties, Frontiers in Bioengineering and Biotechnology ... diverse and emerging bioengineering and biotechnology research to ... in Bioengineering and Biotechnology will provide an ...
(Date:5/23/2013)... In an age when microbial pathogens are growing ... down infection, a team of Wisconsin scientists has synthesized ... the bacteria that cause staph infections. , Writing online ... , a group led by University of Wisconsin-Madison chemistry ... the "quorum sensing" behavior of Staphylococcus aureus , ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2University of Wisconsin chemists find new compounds to curb staph infection 2
... It is estimated that 38 million people worldwide are ... are added each year. For scientists to design treatment ... essential to learn more about how the virus mutates ... by University of Victoria biomedical engineer Stephanie Willerth has ...
... III efficacy data from the GeparQuinto study, a head-to-head ... chemotherapy for patients with early breast cancer, at the ... Dec. 8-12. "We had a primary goal ... trastuzumab, with the new combination of chemotherapy and lapatinib," ...
... Alexandria, VA America has made great strides in recent ... to other, low or non-carbon energy sources. Meanwhile, carbon emissions ... looks at this disparity and asks the difficult questions about ... is imported from "cleaner" countries and the emissions are produced ...
Cached Biology News:UVic biomedical engineer 'outsmarts' HIV 2Phase III study compared neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer 2
... system for detection of very low level ... Equipped with an extreme sensitive camera to ... plants in tumor research, infectious disease research, ... NightOWL is the only imager with a ...
... (Complex Object Parametric Analyzer and Sorter) large ... the advantages of flow cytometry to applications ... for automated analysis and sorting. Our ... as traditional flow cytometers, but are designed ...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
...
Biology Products: